Shlomi Schwartzblat

Van Leer Technology Ventures Jerusalem Ltd. (VLTVJ) is a leading Israeli high technology incubator and investment center which was formerly known as Docor-Shalem Technology Entrepreneurship Center Ltd. Established in 1992 by a consortium of sponsors including Intel, Teva Pharmaceuticals, AVX, Motorola and the Jerusalem Development Authority, VLTVJ aims to find and to foster entrepreneurs with high potential for creating successful technological companies. The firm is located in Jerusalem and is supported by their investors, Docor International BV and The Jerusalem Development Authority. They work with the office of the Chief Scientist within Israel's Ministry of Industry Trade and Employment, seeking to strengthen the Israeli economy and position Jerusalem as a leading city in the high-technology industry. VLTVJ embraces values that they believe reflect strong business practices and good citizenship and requires their investee companies to join them in 'doing good while doing well.'

Colospan Ltd. operates as a clinical stage and medical device company that develops a technology for colorectal surgery to prevent the profound clinical and economic pains associated with colorectal anastomotic leaks and diverting stomas. The company was founded by Boaz Assaf in December 2010 and is headquartered in Kfar Saba, Israel.

EVE Medical Systems Ltd. developed system for diagnosis and treatment of severe premenstrual syndrome in women. Its products included diagnostics of sensitivity to female reproductive hormones, which predominated in the severe cases of different hormone-related conditions, such as premenstrual syndrome unexplained recurrent abortions and personalized treatment solutions. The company was founded by Igor Derzy and Alek M. Itsekson on May 18, 2008 and was headquartered in Jerusalem, Israel.

Promyco Diagnostics has recognized the unmet need for sensitive and accurate serological diagnostic kits for the detection of genital mycoplasma infections. Promyco Diagnostics' research laboratories are located at Soroka University Medical Center, Beer Sheba, Israel. The development of its novel commercial kit is based on the extensive knowledge and expertise accumulated at the NationalCenter for Mycoplasma Laboratory, in the same institution, which specializes and centralizes the clinical testing of mycoplasma infections from samples throughout Israel. This Center was founded and lead for over 20 years by Promyco Diagnostics' scientific leader, Professor Shulamith Horowitz. Promyco Diagnostics' novel serological kit is already in use at this laboratory; many hundreds of samples have proved the concept behind its technology, which will be shortly translated into a simple and accurate commercial kit. The company was founded by Mor Research Applications, the technology transfer company of Israel's biggest Health Care Services, Kupat Holim Clalit, and Van Leer Ventures, one of the leading early stage investment centers.

Secure Islands Technologies Ltd. develops and markets information protection and control solutions. Its services include securere islands IQprotector training, quick start program, on-site consulting and implementation, microsoft RMS consulting, planning and implementation. The company was founded by Aki Eldar and Yuval Eldar in 2006 and is headquartered in Beit-Dagan, Israel.

OptiCul Diagnostics Ltd. designs, patents and markets medical diagnosis devices. The firm's devices measure the response of various samples, such as bodily fluids and secretions, and analyze them to detect the presence of different bacteria. The company was founded by Moshe Ben-David, Shimon Eckhouse, Israel Gannot and Gallya Gannot in January 2008 and is headquartered in Jerusalem, Israel.

Utilizing proprietary, state-of-the-art computer-vision technologies, XSIGHTS is a software and service provider focused on transforming Static media, (newspapers, magazines, wall-posters, books, DVD covers, etc.) to an interactive multi-media experience for the users, through their mobile handset. XSIGHTS platform enables the reader to enjoy multimedia content while opening new opportunities for targeted advertising. XSIGHTS' unique technology enables publishers to convert any item in the paper, even a single word, to a Hyperlink. Outside the house, readers can use their mobile camera-phone to capture images of a printed item. XSIGHTS understands these images, and delivers to the user an Interactive content.

Bonfix Ltd. develops orthopedic implant to treat deformities. It engages in the development of an orthopedic implant to treat deformities related to Hallux Valgus (Bunions). The Bonfix implant offers a minimally invasive procedure to realign the 1st and 2nd metatarsals. The company was founded by Dror Robinsonin 2009 and is headquartered in Jerusalem, Israel.